Question 1

What is Rhythm Pharmaceuticals?

Accepted Answer

Rhythm Pharmaceuticals is a Company.

Question 2

How often does Rhythm Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 9 news events drawn from 55 articles.

Question 3

When was Rhythm Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Feb 14, 2026.

Question 4

When was Rhythm Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Aug 21, 2026.

Question 5

What is Rhythm Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 3 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Rhythm Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 9 events.

Question 7

What is the most recent event involving Rhythm Pharmaceuticals?

Accepted Answer

Inovio Pharmaceuticals Class Action Deadline (Apr 01, 2026, 7 articles).

Question 8

How did the "Inovio Pharmaceuticals Class Action Deadline" event impact Rhythm Pharmaceuticals?

Accepted Answer

Rhythm Pharmaceuticals is the defendant in a class action lawsuit, accused of making false and misleading statements regarding its CELLECTRA device and INO-3107 Biologics License Application.

Question 9

How did the "Inovio_Pharmaceuticals faces shareholder lawsuit" event impact Rhythm Pharmaceuticals?

Accepted Answer

Rhythm Pharmaceuticals is facing a federal securities lawsuit alleging that its officers and directors breached fiduciary duties by misrepresenting or failing to disclose critical information regarding its CELLECTRA device and INO-3107 BLA submission.

Question 10

How did the "INOVIO $20M public offering" event impact Rhythm Pharmaceuticals?

Accepted Answer

INOVIO is raising $20M through a dilutive public offering, which may pressure its stock price but provides capital for its DNA medicine programs.

Question 11

How did the "FDA tentative approval for OMCAZIO capsules" event impact Rhythm Pharmaceuticals?

Accepted Answer

Rhythm Pharmaceuticals is the developer and sponsor of OMCAZIO. The tentative approval is a major regulatory milestone that advances its oncology pipeline and commercial prospects.

Question 12

How did the "Alvotech Lotus biosimilar licensing agreement" event impact Rhythm Pharmaceuticals?

Accepted Answer

Lotus secures exclusive commercialization rights in eight Asian markets and U.S. rights via Alvogen, expanding its biosimilar portfolio and global reach.

Question 13

How did the "First-in-Human OsStic Bone Void Filler" event impact Rhythm Pharmaceuticals?

Accepted Answer

Partner on ReFeel; this event highlights PBC Biomed's network but has limited direct impact.

Question 14

How did the "Cocrystal Pharma Appoints Carol Brosgart to Board" event impact Rhythm Pharmaceuticals?

Accepted Answer

Rhythm Pharmaceuticals is noted as a company where Brosgart currently serves on the board; no direct impact.

Question 15

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.